Skip to content

Longitudinal Neuroinflammation Quantification and 3D Lesion Evolution using Magnetic Resonance Imaging: Paving the Way for Personalized Recovery Predictions with Novel Neuroinflammation Treatment Markers - a pilot study

Longitudinal Neuroinflammation Quantification and 3D Lesion Evolution using Magnetic Resonance Imaging: Paving the Way for Personalized Recovery Predictions with Novel Neuroinflammation Treatment Markers - a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039665
Enrollment
40
Registered
2026-03-19
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnosis of traumatic or non-traumatic spinal cord injury (i.e. injury of the spinal cord with or without any external physical impact, AIS A, B, C or D)

Interventions

Group 1: Patients with acute and chronic spinal cord injury will be assessed once or longitudinally using magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and standard clinical

Sponsors

Medizinische Universität Wien
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: General health, meaning no chronic or persistent diseases, except for a diagnosis of traumatic or non-traumatic spinal cord injury, based on medical history, physical examination and clinical interview Willingness and competence to sign the informed consent form. (For patients only) Diagnosis of traumatic or non-traumatic spinal cord injury (i.e. injury of the spinal cord with or without any external physical impact, AIS A, B, C or D).

Exclusion criteria

Exclusion criteria: Women who are pregnant or breast feeding. Failure to comply with the study protocol or to follow the instruction of the investigating team. Any contraindications for MRI, such as non-MRI-safe metal implants (e.g., pacemakers, metal heart valves, surgical clips, implanted electronic infusion pumps, or similar devices). Claustrophobia. Any other neurological or psychiatric disorder.

Design outcomes

Primary

MeasureTime frame
Quantifiable MRI- and MRS-based parameters characterizing structural and biochemical changes in the spinal cord.

Secondary

MeasureTime frame
Association between MRI- and MRS-based parameters and standard clinical neurological examinations. Comparison of MRI and MRS parameters between patients with acute and chronic spinal cord injury and healthy controls. Reproducibility and methodological stability of MRI and MRS parameters across repeated measurements.

Countries

Austria

Contacts

Public ContactTim Max Emmenegger

Medizinische Universität Wien

tim.emmenegger@meduniwien.ac.at+43 (0)1 40400 - 6471

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026